Cor Vasa 2010, 52(7-8):437-440 | DOI: 10.33678/cor.2010.117

Peripheral artery disease: what is the best approach? The diagnostic and therapeutic algorithm for clinical practice

Petra Zimolová
Kardiologické oddělení, Kardiovaskulární centrum, Fakultní nemocnice Motol, Praha, Česká republika

Though a major cause of morbidity in the developed countries, peripheral arterial disease (PAD) belongs to conditions not receiving adequate attention in terms of its prevention, diagnosis, and treatment. A thorough history, proper timing and interpretation of results of examination combined with selection of appropriate therapy may significantly reduce the overall risk of cardiovascular events. At the same time, PAD is a marker of coronary and cerebral atherosclerosis.

Keywords: Peripheral arterial disease; Examination algorithm; Therapeutic options

Published: July 1, 2010  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Zimolová P. Peripheral artery disease: what is the best approach? The diagnostic and therapeutic algorithm for clinical practice. Cor Vasa. 2010;52(7-8):437-440. doi: 10.33678/cor.2010.117.
Download citation

References

  1. Diehm C, Schuster A, Allenberg JR, et al. High prevalence of peripheral arterial disease and co-morbidity in 6880 primary care patients: cross-sectional study. Atherosclerosis 2004;172:95-105. Go to original source...
  2. Norgren L, Hiatt WR, Dormandy JA, et al. Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II). J Vasc Surg 2007; 45:S5-S67. Go to original source... Go to PubMed...
  3. Bulvas M. Doporučení pro diagnostiku a léčbu ischemické choroby dolních končetin. Cor Vasa 2009;51:145-163. Go to original source...
  4. Vaverková H, Soška V, Rosolová H, et al. Doporučení pro diagnostiku a léčbu dyslipidemií v dospělosti, vypracované výborem České společnosti pro aterosklerózu. Cor Vasa 2007;49:K73-K86.
  5. Pande RL, Hiatt WR, Zhang P, et al. A pooled analysis of the durability and predictors of treatment response of cilostazol in patients with intermittent claudication. Vasc Med 2010;15:181-188. Go to original source... Go to PubMed...
  6. Chochola M. Buněčná terapie v léčbě chronické kritické končetinové ischémie. Postgrad Med 2006;8:442-446.
  7. Tepe G, Zeller T, Albrecht T, et al. Local delivery of paclitaxel to inhibit restenosis during angioplasty of the leg. N Engl J Med 2008;358:689-699. Go to original source... Go to PubMed...
  8. Tepe G, Schmitmeier S, Speck U, et al. Advances on drug-coated balloons. J Cardiovasc Surg (Torino) 2010;51:125-143. Go to PubMed...




Cor et Vasa

You are accessing a site intended for medical professionals, not the lay public. The site may also contain information that is intended only for persons authorized to prescribe and dispense medicinal products for human use.

I therefore confirm that I am a healthcare professional under Act 40/1995 Coll. as amended by later regulations and that I have read the definition of a healthcare professional.